ArticlemAbs2019

Antibody-drug conjugates with HER2-targeting antibodies from synthetic antibody libraries are highly potent against HER2-positive human gastric tumor in xenograft models.

Wei-Ying Kuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.